КОЛИЧЕСТВЕННАЯ ОЦЕНКА КЛИНИЧЕСКОЙ КАРТИНЫ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ
L., Kim Y. et al. Lov-astatin inhibits proliferation of rat mesangial cells // J. Clin. Invest. - 1993. - 91. - 83-87.
18. Parving H.-H., Osterly R., Huderson P.W., Hsuch W.A. Diabetic nephropathy / In: Brenner B.M.,
ed. The Kidney. 5th end. Vol. 2, W.B. Saunders, Philadelphia, 1996. - P. 1864-1892.
19. Renal Data System, USRDS 1996 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases,
Bethesda, MD, 1997.
20.Salahudeen A.K., Kanji V., Reckelhoff J.F. et al.Pathogenesis of diabetic nephropathy: a radical approach // Nephrol. Dial. Transplant. - 1997. - Vol. 12.
- P. 664-668.
21. Sasaki T., Kurata H., Nomura K. et al. Amelioration of proteinuria with pravastatin in hypercholes-terolaemic patiens with diabetes mellitus. Jap. J. Med.
- 1990. - Vol. 29. - P.156-163
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52